Hence, the α-PD-L1 antibody itself shaped the tumor microenvironment by eradicating immunosuppressive cell populations (i.e., CD11b+PD-L1+, CD206+PD1+) and promoting infiltration of antigen-presenting cells (CD11c+). The gene discussed is ITGAX; the disease is neoplasm.